Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
Reason for recall: Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg). Distribution: Distributed Nationwide in the USA Quantity: 2,064 100-count bottles Lot/code info: Lot # CS25070, exp. date 03/31/2027
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.